Search

H Lundbeck A-S

Closed

30.34 0.46

Overview

Share price change

24h

Current

Min

29.62

Max

31.18

Key metrics

By Trading Economics

Income

-221M

590M

Sales

-181M

5.5B

P/E

Sector Avg

9.969

54.379

EPS

1.36

Dividend yield

3.01

Profit margin

10.648

Employees

5,707

EBITDA

-193M

811M

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.01%

2.55%

Market Stats

By TradingEconomics

Market Cap

31B

Previous open

29.88

Previous close

30.34

H Lundbeck A-S Chart

Past performance is not a reliable indicator of future results.

Related News

12 May 2025, 22:34 UTC

Acquisitions, Mergers, Takeovers

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12 May 2025, 23:48 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

12 May 2025, 23:46 UTC

Market Talk

Nikkei Likely to Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

12 May 2025, 23:34 UTC

Market Talk

Trade Deal Lowers US Recession Risks to 35% -- Market Talk

12 May 2025, 23:21 UTC

Market Talk

US-China Trade Deal Still Risks Stagflation; Supply Chain Disruption -- Market Talk

12 May 2025, 22:54 UTC

Market Talk

Australian Treasurer Warns Uncertainty Will Still Dominate Markets -- Market Talk

12 May 2025, 22:43 UTC

Earnings

Telefonica Brasil 1Q EPS BRL0.65 >VIV

12 May 2025, 22:14 UTC

Top News

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12 May 2025, 22:08 UTC

Acquisitions, Mergers, Takeovers

Ampol Expects Replacement-Cost Ebitda Uplift by Run Rate at End-2025 of Around A$30 Million/Year

12 May 2025, 22:08 UTC

Acquisitions, Mergers, Takeovers

Ampol Expects Pretax Proceeds of Around A$65 Million From Transactions

12 May 2025, 22:07 UTC

Acquisitions, Mergers, Takeovers

Ampol to Sell Australia Retail Electricity Business for Nominal Sum

12 May 2025, 22:07 UTC

Acquisitions, Mergers, Takeovers

Ampol to Sell Australia Retail Electricity Business to AGL

12 May 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

Meridian to Take on Flick, Z Energy Branded Electricity Customers

12 May 2025, 22:06 UTC

Acquisitions, Mergers, Takeovers

Meridian Energy to Buy Business From Ampol for NZ$70 Million

12 May 2025, 22:05 UTC

Acquisitions, Mergers, Takeovers

Ampol to Sell New Zealand Electricity Retailing Businesses to Meridian Energy

12 May 2025, 22:04 UTC

Acquisitions, Mergers, Takeovers

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12 May 2025, 21:15 UTC

Top News

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- 2nd update -- WSJ

12 May 2025, 21:01 UTC

Earnings

Constellation Software 1Q Rev $2.65B >CSU.T

12 May 2025, 21:01 UTC

Earnings

Constellation Software 1Q Net $115M >CSU.T

12 May 2025, 21:01 UTC

Earnings

Constellation Software 1Q EPS $5.44 >CSU.T

12 May 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12 May 2025, 20:50 UTC

Market Talk
Earnings

Basic Materials Roundup: Market Talk

12 May 2025, 20:44 UTC

Top News

Trade Thaw Sparks Stock Rally, Leaves Wall Street Cautious -- WSJ

12 May 2025, 20:31 UTC

Top News

How to Think About the Stock Market When Earnings Guidance Becomes Meaningless -- Heard on the Street -- UPDATED -- WSJ

12 May 2025, 20:24 UTC

Earnings

Energy Vault Holdings: Encouraging News on China/U.S. Tariff Pause, Pending Final Positive Resolution and Timing >NRGV

12 May 2025, 20:24 UTC

Earnings

Energy Vault Holdings: No Change to Current Guidance, With Potential Rev Upside on Accelerated U.S. Battery Deliveries in 2025 >NRGV

12 May 2025, 20:24 UTC

Top News

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- WSJ

12 May 2025, 20:22 UTC

Acquisitions, Mergers, Takeovers

Spirit AeroSystems Holdings: IRS Rules That Sale to Boeing Will Qualify as a Reorganization Under Section 368(a)(1)(B)

12 May 2025, 20:15 UTC

Earnings

Rigetti Computing Reports Earnings. How the Company Takes a Different Approach to Quantum. -- Barrons.com

12 May 2025, 20:10 UTC

Earnings

Blink Charging 1Q Rev $20.8M >BLNK

H Lundbeck A-S Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About H Lundbeck A-S

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company's principal products include Abilify Maintena/Abilify Maintena for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat MDD and schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat dementia; Onfi for epilepsy; Sabril for the treatment of refractory complex partial seizures and infantile spasms; Xenazine for chorea; Deanxit for depression; Cipramil for depression and anxiety; and Cisordinol to treat psychosis. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark.